Initial general form for registration of a class of securities pursuant to Section 12(g)

Summary of Statement of Operations Acquisition (Details)

v3.22.1
Summary of Statement of Operations Acquisition (Details) - USD ($)
 3 Months Ended 6 Months Ended 12 Months Ended
Dec. 31, 2021
Sep. 30, 2021
Dec. 31, 2020
Sep. 30, 2020
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2021
Jun. 30, 2021
Jun. 30, 2020
Business Acquisition [Line Items]                  
Net Revenues         $ 245,991 $ 245,991
General and Administrative expenses         699,830 5,505   507,768 17,913
Depreciation and amortization         97,511      
Total Operating Expenses         934,988 7,670   507,768 17,913
Loss from Operations         (688,997) (7,670)   (507,768) (17,913)
Other (Expense)         99,974  
Net Loss $ (292,663) $ (296,360) $ (3,260) $ (4,410) $ (589,023) $ (7,670)   $ (507,768) $ (17,913)
Basic and Diluted (loss) per share         $ (0.00) $ (0.00)   $ (0.00) $ (0.00)
Basic and Diluted weighted average common shares outstanding         234,953,286 249,418,545   249,220,391 249,418,545
Rennova Health Inc [Member]                  
Business Acquisition [Line Items]                  
Net Revenues           $ 266,446   $ 493,621  
Direct costs of revenues             7,166  
General and Administrative expenses           794,262   1,343,436  
Depreciation and amortization           96,800   195,055  
Total Operating Expenses           891,062   1,545,657  
Loss from Operations           (624,616)   (1,052,036)  
Other (Expense)           (62,703)   (42,103)  
Net Loss           $ (687,319)   (1,094,139)  
Net loss attributed to common stockholders               $ (1,861,639)  
Basic and Diluted (loss) per share           $ (0.00)   $ (0.00)  
Basic and Diluted weighted average common shares outstanding           234,953,286   234,953,286